4 Smallcap Compounding Stocks to Watch for Future Multibagger Potential: Elgi Equipments, CCL Products, Vijaya Diagnostic and Stylam Industries
- October 23, 2026
- Posted by: Manan Bisht
- Category: Best Stocks
Elgi Equipments Rs 534. CCL Products Rs 986.80. Vijaya Diagnostic Rs 1,368.20. Stylam Industries Rs 3,305.20. Market caps from Rs 5,609 crore to Rs 18,186 crore. Data as of 22 Oct 2026.
Quick Answer
Elgi Equipments, CCL Products, Vijaya Diagnostic and Stylam Industries are the 4 picks in this compounding stocks watchlist, with market caps between Rs 5,609 crore and Rs 18,186 crore. Elgi Equipments stands out for the highest return on equity at 19.28%, while CCL Products offers 43.40% revenue growth in FY26. PE ratios run from 33.04 to 75.90, so compare each one with its industry PE before investing. All figures are as of 22 October 2026.
Compounding stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Elgi Equipments, CCL Products, Vijaya Diagnostic and Stylam Industries meet that test, with market caps from Rs 5,609 crore to Rs 18,186 crore and Elgi Equipments offering the highest return on equity at 19.28%. Each of these companies has a market capitalisation below Rs 30,000 crore and a five-year return above 100 per cent, a return on equity above 15 per cent and FY26 profit growth of at least 15 per cent, and net profit rose in FY26 and in the latest quarter.
This list covers companies with a market capitalisation below Rs 30,000 crore and a five-year return above 100 per cent, a return on equity above 15 per cent and FY26 profit growth of at least 15 per cent, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap below Rs 30,000 crore. Investors screening compounding stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 22 October 2026 and are drawn from NSE and BSE data and company filings.
Click Here – Get Free Investment Predictions
What Are Compounding Stocks and Why Do They Attract Multibagger Interest?
Compounding stocks are shares of smaller companies that have more than doubled in five years on the back of rising profit. The four here cover compressors, instant coffee, diagnostics and laminates.
Smaller companies with high returns on equity can compound faster than larger peers. For compounding stocks, both FY26 and the latest quarter showed growth. With compounding stocks, comparing valuation, growth and balance sheet strength together works better than relying on one number. Every company in the table below passed a rising-profit check, and the figures for compounding stocks are complete. Read each company’s latest results and exchange filings before acting on compounding stocks.
Compounding Stocks at a Glance: Price, Market Cap, PE and ROE
Prices are closing prices as of 22 October 2026. Stylam Industries has the lowest PE of the group at 33.04, while Elgi Equipments posts the highest return on equity at 19.28%.
| Stock | CMP (Rs) | Market Cap (Rs Cr) | PE | Industry PE | ROE | Debt to Equity | 52-Week Range (Rs) |
|---|---|---|---|---|---|---|---|
| Elgi Equipments | 534 | 18,186 | 40.61 | 45.93 | 19.28% | 0.24 | 408.25 to 653.40 |
| CCL Products India | 986.80 | 14,463 | 33.44 | 24.20 | 16.55% | 0.56 | 818.75 to 1,242.20 |
| Vijaya Diagnostic Centre | 1,368.20 | 14,228 | 75.90 | 60.75 | 18.07% | 0.44 | 848.00 to 1,593.60 |
| Stylam Industries | 3,305.20 | 5,609 | 33.04 | 36.42 | 18.57% | 0.04 | 1,861.00 to 4,150.00 |
Elgi Equipments: 24.61% Profit CAGR Since FY22
Elgi Equipments makes air compressors for industrial customers in India and overseas. It reported FY26 revenue of Rs 4,068.50 crore, up 14.02% year on year, and net profit of Rs 430.20 crore, up 22.84%. Net profit has compounded at 24.61% a year since FY22, while revenue has grown 12.06% a year. Operating margin was 17.53% in FY26. The debt-to-equity ratio is 0.24.
In the June 2026 quarter, revenue rose 22.13% to Rs 1,082.60 crore and net profit grew 20.68% to Rs 103.30 crore. The share price has gained 182.78% over five years and 21.42% over the past year. Domestic institutions raised their holding from 5.23% in June 2025 to 10.13% in June 2026. The stock trades at a PE of 40.61 against an industry PE of 45.93, below the sector average, with a return on equity of 19.28%.
CCL Products: Revenue Up 43.40% in FY26
CCL Products India is one of the largest private-label and instant coffee makers in the world and exports to many countries. It reported FY26 revenue of Rs 4,465.80 crore, up 43.40% year on year, and net profit of Rs 388.11 crore, up 25.06%. Net profit has compounded at 17.39% a year since FY22, while revenue has grown 32.11% a year. Operating margin was 16.63% in FY26.
The stock trades at a PE of 33.44 against an industry PE of 24.20, with a return on equity of 16.55%. In the September 2026 quarter, revenue rose 7.78% to Rs 1,215.99 crore and net profit grew 28.98% to Rs 130.09 crore. The share price has gained 145.27% over five years and 18.32% over the past year. Foreign investors raised their holding from 10.53% in September 2025 to 12.12% in September 2026.
Vijaya Diagnostic: Quarterly Profit Up 37.60%
Vijaya Diagnostic Centre runs diagnostic centres offering pathology and radiology services, with a strong base in South India. It reported FY26 revenue of Rs 835 crore, up 19.34% year on year, and net profit of Rs 172.98 crore, up 20.30%. Net profit has compounded at 11.81% a year since FY22, while revenue has grown 15.13% a year. Operating margin was 43.94% in FY26. The debt-to-equity ratio is 0.44.
In the June 2026 quarter, revenue rose 22.76% to Rs 239.51 crore and net profit grew 37.60% to Rs 53.10 crore. The share price has gained 141.31% over five years and 38.44% over the past year. Domestic institutions raised their holding from 25.34% in September 2025 to 32.50% in September 2026. The stock trades at a PE of 75.90 against an industry PE of 60.75, with a return on equity of 18.07%.
Stylam Industries: 25.14% Profit CAGR Since FY22
Stylam Industries makes decorative laminates, compact laminates and allied surfacing products, and exports them to many countries. It reported FY26 revenue of Rs 1,136.09 crore, up 10.02% year on year, and net profit of Rs 149.87 crore, up 22.98%. Net profit has compounded at 25.14% a year since FY22, while revenue has grown 14.23% a year. Operating margin was 20.15% in FY26. The debt-to-equity ratio is 0.04, which keeps interest costs low.
The stock trades at a PE of 33.04 against an industry PE of 36.42, below the sector average, with a return on equity of 18.57%. In the June 2026 quarter, revenue rose 15.48% to Rs 327.69 crore and net profit grew 70.36% to Rs 48.16 crore. The share price has gained 213.14% over five years and 72.69% over the past year. Promoters hold 56.86%, which keeps ownership stable.
Compounding Stocks: Financial Comparison on Growth and Margins
The table compares scale and growth across these compounding stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.
| Stock | Revenue (Rs Cr) | Net Profit (Rs Cr) | Revenue Growth (YoY) | 4-Year Revenue CAGR | 4-Year Net Profit CAGR | Operating Margin (Latest Quarter) |
|---|---|---|---|---|---|---|
| Elgi Equipments | 4,068.50 | 430.20 | 14.02% | 12.06% | 24.61% | 16.02% |
| CCL Products | 4,465.80 | 388.11 | 43.40% | 32.11% | 17.39% | 17.95% |
| Vijaya Diagnostic | 835 | 172.98 | 19.34% | 15.13% | 11.81% | 46.35% |
| Stylam Industries | 1,136.09 | 149.87 | 10.02% | 14.23% | 25.14% | 21.46% |
Check the Univest Screener for live data on these compounding stocks
Institutional Holding in Elgi Equipments, CCL Products, Vijaya Diagnostic and Stylam Industries
Institutional holding shows who is backing these compounding stocks alongside the promoter. The table uses the latest reported quarter for each. Vijaya Diagnostic has the deepest institutional backing, with FII and DII together holding 43.16% as of September 2026. Domestic institutions increased their holding over the past year in Elgi Equipments (from 5.23% to 10.13%) and Vijaya Diagnostic (from 25.34% to 32.50%).
| Stock | Promoter | FII | DII | Public | Quarter |
|---|---|---|---|---|---|
| Elgi Equipments | 31.19% | 21.90% | 10.13% | 36.78% | June 2026 |
| CCL Products | 46.16% | 12.12% | 21.41% | 20.31% | September 2026 |
| Vijaya Diagnostic | 52.46% | 10.66% | 32.50% | 4.38% | September 2026 |
| Stylam Industries | 56.86% | 2.62% | 12.14% | 28.39% | June 2026 |
Risks to Weigh in Compounding Stocks
Being careful with compounding stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:
- Past growth may not repeat.
- Share prices can move sharply in either direction.
- Valuation: CCL Products trades at a PE of 33.44 against an industry PE of 24.20, so earnings need to keep growing to support the price.
- Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.
How to Choose Between Compounding Stocks
Picking from compounding stocks comes down to four checks, applied in order.
- Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
- Compare each PE with the industry PE (24.20 to 60.75) and ask whether the growth rate justifies any gap.
- Track net profit growth, the operating margin and the return on equity in every quarterly result.
- Stagger entries across quarters and review institutional holding every reporting season.
Download the Univest iOS App or Univest Android App to track Elgi Equipments, CCL Products, Vijaya Diagnostic and Stylam Industries live prices.
Conclusion
Among compounding stocks, Elgi Equipments stands out for the highest return on equity at 19.28%, CCL Products for 43.40% revenue growth in FY26, Vijaya Diagnostic for 19.34% revenue growth in FY26 and Stylam Industries for the fastest profit growth, 25.14% a year since FY22. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing compounding stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Compounding Stocks to Watch
Which are the best compounding stocks to watch for multibagger potential?
Ans. Elgi Equipments, CCL Products, Vijaya Diagnostic and Stylam Industries are the 4 names this list highlights, with market caps of Rs 18,186 crore, Rs 14,463 crore, Rs 14,228 crore and Rs 5,609 crore respectively. Elgi Equipments is notable for the highest return on equity at 19.28%. CCL Products stands out for 43.40% revenue growth in FY26. Vijaya Diagnostic offers 19.34% revenue growth in FY26. Stylam Industries brings the fastest profit growth, 25.14% a year since FY22. These are watchlist names for compounding stocks, not recommendations, so match each one to your own risk profile and time horizon.
Is Elgi Equipments a good stock for long-term investors?
Ans. Elgi Equipments has a return on equity of 19.28%, a PE of 40.61 against an industry PE of 45.93 and a market cap of Rs 18,186 crore. Net profit has compounded at 24.61% a year since FY22, and FY26 revenue rose 14.02% while June 2026 quarter net profit grew 20.68%. Long-term returns in compounding stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.
Can Stylam Industries become a multibagger from here?
Ans. Stylam Industries has already gained 213.14% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in compounding stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 25.14% a year since FY22, and FY26 revenue rose 10.02%. At a PE of 33.04 against an industry PE of 36.42, valuation should be checked against that growth before investing.
What is the market cap of Elgi Equipments, CCL Products, Vijaya Diagnostic and Stylam Industries?
Ans. As of 22 October 2026, Elgi Equipments has a market cap of Rs 18,186 crore, CCL Products has a market cap of Rs 14,463 crore, Vijaya Diagnostic has a market cap of Rs 14,228 crore and Stylam Industries has a market cap of Rs 5,609 crore. All of them qualify as smallcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on compounding stocks.
What are the risks of investing in compounding stocks?
Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. CCL Products trades at a PE of 33.44 against an industry PE of 24.20, so earnings growth needs to hold up.
Why is CCL Products trading at a PE of 33.44?
Ans. CCL Products’ PE of 33.44 compares with an industry PE of 24.20. The market is paying a premium for a return on equity of 16.55%, profit growth of 17.39% a year since FY22 and latest-quarter profit growth of 28.98%, which also means the stock is more sensitive if growth slows. Investors in compounding stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.
How much do institutions hold in Elgi Equipments, CCL Products, Vijaya Diagnostic and Stylam Industries?
Ans. As of the latest reported quarter, FII and DII together hold 32.03% of Elgi Equipments (21.90% and 10.13%), 33.53% of CCL Products (12.12% and 21.41%), 43.16% of Vijaya Diagnostic (10.66% and 32.50%) and 14.76% of Stylam Industries (2.62% and 12.14%). Rising institutional holding is a useful signal in compounding stocks, though it should be read with earnings trends rather than on its own.
